多发性炎症性肠病家族中微生物失调的年龄相关模式
研究在多发性炎症性肠病(IBD)家族中探究粪便和血清失调标志物的年龄相关模式。从婴儿期至8岁,微生物和代谢失调参数逐步下降,母亲患IBD的婴儿该成熟过程较慢;15岁后未患病亲属的失调随成年持续增加。失调与抗菌血清学升高相关,但与粪便钙卫蛋白无关;联合钙卫蛋白、粪便代谢失调指数和血清学评分的模型准确率最高。
要点
- 多发性IBD家族中,微生物和代谢失调参数从婴儿期至8岁逐步下降。
- 母亲患IBD的婴儿微生物成熟过程较慢;15岁后未患病亲属失调随成年持续增加。
- 联合钙卫蛋白、粪便代谢失调指数和血清学评分的模型区分IBD与非IBD准确率最高。
核心结论
- 失调作为可检测的疾病前状态存在,粪便和血清生物标志物可用于IBD风险预测。
- 所开发的指数可能促进高危个体的早期诊断和改善管理。
研究设计与样本
- 收集多发性IBD家族和对照家族的粪便和血清样本(95例IBD、292例未患病、51例对照)。
- 在616和1173名受试者的独立队列中验证发现,包括IBD患者、母亲患IBD的婴儿和对照。
- 进行16S rRNA基因测序和粪便及血清的全局非靶向代谢组学分析。
主要发现
- 微生物和代谢失调参数从婴儿期至8岁逐步下降。
- 母亲患IBD的婴儿微生物成熟过程较慢。
- 15岁后,未患病亲属的失调在整个成年期稳步增加。
- 失调伴随粪便代谢组显著变化,血清代谢组变化较小。
- 粪便和血清代谢组失调指数在独立队列中得到验证。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: IBD is characterised by dysbiosis, but it remains unclear to what extent dysbiosis develops in unaffected at-risk individuals. To address this, we investigated age-related patterns of faecal and serum markers of dysbiosis in high-risk multiplex IBD families (two or more affected first-degree relatives). DESIGN: Faecal and serum samples were collected from multiplex IBD and control families (95 IBD, 292 unaffected, 51 controls). Findings were validated in independent cohorts of 616 and 1173 subjects including patients with IBD, infants born to mothers with IBD and controls. 16S rRNA gene sequencing and global untargeted metabolomics profiling of faeces and serum were performed. RESULTS: Microbial and metabolomic parameters of dysbiosis progressively decreased from infancy until age 8. This microbial maturation process was slower in infants born to mothers with IBD. After age 15, dysbiosis steadily increased in unaffected relatives throughout adulthood. Dysbiosis was accompanied by marked shifts in the faecal metabolome and, to a lesser extent, the serum metabolome. Faecal and serum metabolomics dysbiosis indices were validated in an independent cohort. Dysbiosis was associated with elevated antimicrobial serologies but not with faecal calprotectin. Dysbiosis metrics differentiated IBD from non-IBD comparably to serologies, with a model combining calprotectin, faecal metabolomics dysbiosis index and serology score demonstrating highest accuracy. CONCLUSION: These findings support that dysbiosis exists as a pre-disease state detectable by faecal and serum biomarkers for IBD risk prediction. Given the expansion of disease-modifying agents and non-invasive imaging, the indices developed here may facilitate earlier diagnoses and improved management in at-risk individuals.
引用
- Jacobs JP, Spencer EA, Helmus DS, et al. Age-related patterns of microbial dysbiosis in multiplex inflammatory bowel disease families. Gut. 2024. PMID: 39122361. doi:10.1136/gutjnl-2024-332475
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。